Sandoz targets 70% price cut for weight-loss drugs in Canada, FT reports

(Reuters) -Swiss generic drug manufacturer Sandoz plans to introduce unbranded weight-loss drugs in Canada at up to a 70% discount compared to branded versions when patents begin expiring next year, CEO Richard Saynor told the Financial Times.

(Reporting by Bipasha Dey in Bengaluru; Editing by Nivedita Bhattacharjee)